Chengdu Olymvax Biopharmaceuticals (SHSE:688319) Net Income Including Noncontrolling Interests : ¥36.0 Mil (TTM As of Mar. 2025)

View and export this data going back to 2021. Start your Free Trial

What is Chengdu Olymvax Biopharmaceuticals Net Income Including Noncontrolling Interests?

Net Income Including Noncontrolling Interests is the net income of the group after the adjustment of all expenses and benefit. It includes the net income (loss) attributable to noncontrolling and redeemable noncontrolling interests and the net income (loss) attributable to the company.

Chengdu Olymvax Biopharmaceuticals's Net Income Including Noncontrolling Interests for the three months ended in Mar. 2025 was ¥-7.0 Mil. Its Net Income Including Noncontrolling Interests for the trailing twelve months (TTM) ended in Mar. 2025 was ¥36.0 Mil.

Chengdu Olymvax Biopharmaceuticals Net Income Including Noncontrolling Interests Historical Data

The historical data trend for Chengdu Olymvax Biopharmaceuticals's Net Income Including Noncontrolling Interests can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Chengdu Olymvax Biopharmaceuticals Net Income Including Noncontrolling Interests Chart

Chengdu Olymvax Biopharmaceuticals Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Net Income Including Noncontrolling Interests

Get a 7-Day Free Trial

36.13

107.96

26.58

11.44

15.72

Chengdu Olymvax Biopharmaceuticals Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Net Income Including Noncontrolling Interests	Get a 7-Day Free Trial															-27.30	-3.42	30.64	15.80	-7.04

Chengdu Olymvax Biopharmaceuticals Net Income Including Noncontrolling Interests Calculation

Net Income Including Noncontrolling Interests for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥36.0 Mil.

Chengdu Olymvax Biopharmaceuticals Net Income Including Noncontrolling Interests Related Terms

Thank you for viewing the detailed overview of Chengdu Olymvax Biopharmaceuticals's Net Income Including Noncontrolling Interests provided by GuruFocus.com. Please click on the following links to see related term pages.

Chengdu Olymvax Biopharmaceuticals Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Chengdu Olymvax Biopharmaceuticals Inc (SHSE:688319) » Definitions » Net Income Including Noncontrolling Interests

Comparable Companies

Traded in Other Exchanges

N/A

Address

99 Tianxin Road, High-tech Zone, Sichuan Province, Chengdu, CHN, 611731

Website

http://www.olymvax.com

Chengdu Olymvax Biopharmaceuticals Inc is engaged in the research and development, production, and sales of human vaccines, focusing on innovative products.

Executives

Wu Qiang	Core technical personnel
Chen Dao Yuan	Core technical personnel
Li Hong Guang	Core technical personnel
Fan Shao Wen	Directors, senior managers
Ma Heng Jun	senior management
Wu Wei	senior management
Fan Fan	Director
Chen Ai Min	Director
Tan Yong	senior management
Lu Lu	Director
Yu Yun Hui	Director
Zhang Li Ying	Core technical personnel
Chen Ke Ping	Core technical personnel
Yang Feng	Core technical personnel

Chengdu Olymvax Biopharmaceuticals Headlines

No Headlines